Cochlin expression in anterior segment organ culture models after TGFβ2 treatment

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 551-559

  Bhattacharya, Sanjoy K ^a   Gabelt, B'Ann T ^b   Ruiz, Jose ^a   Picciani, Renata ^a   Kaufman, Paul L ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCHLIN; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA2; COCH PROTEIN, HUMAN; PROTEIN; RECOMBINANT PROTEIN; TGFB2 PROTEIN, HUMAN;

ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAOCULAR PRESSURE; MACACA; MALE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TRABECULAR MESHWORK; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; ORGAN CULTURE TECHNIQUE;

ANIMALS; ANTERIOR EYE SEGMENT; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; MACACA MULATTA; ORGAN CULTURE TECHNIQUES; PROTEINS; RECOMBINANT PROTEINS; SWINE; TRANSFORMING GROWTH FACTOR BETA2;

EID: 59449103345     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2632     Document Type: Article

References (26)

1. Coleman AL. Epidemiology of Glaucoma. In: Morrison JC, Pollack IP. Glaucoma Science and Practice. New York: Thieme Medical Publishers Inc.; 2003;2-11.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
3. Morrison JC, Acott TS. Anatomy and physiology of aqueous humor outflow. In: Morrison JC, Pollack IP. Glaucoma Science and Practice. New York: Thieme Medical Publishers Inc.; 2003;34-41.
4. Lütjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res. 1999;18:91-119.
5. Lütjen-Drecoll E. Importance of trabecular meshwork changes in the pathogenesis of primary open-angle glaucoma. J Glaucoma. 2000;9:417-418.
6. Bhattacharya SK, Rockwood EJ, Smith SD, et al. Proteomics reveals cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem. 2005;280:6080-6084.
7. Bhattacharya SK, Peachey NS, Crabb JW. Cochlin and glaucoma: a mini-review. Vis Neurosci. 2005;22:605-613.
8. Picciani R, Desai K, Guduric-Fuchs J, Cogliati T, Morton CC, Bhattacharya SK. Cochlin in the eye: functional implications. Prog Retin Eye Res. 2007;26(5):453-469.
9. Robertson NG, Khetarpal U, Gutierrez-Espeleta GA, Bieber FR, Morton CC. Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. Genomics. 1994;23:42-50.
10. Robertson NG, Skvorak AB, Yin Y, et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics. 1997;46:345-354.
11. Robertson NG, Hamaker SA, Patriub V, Aster JC, Morton CC. Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet. 2003;40: 479-486.
12. Grabski R, Szul T, Sasaki T, et al. Mutations in COCH that result in non-syndromic autosomal dominant deafness (DFNA9) affect matrix deposition of cochlin. Hum Genet. 2003;113:406-416.
13. Bhattacharya SK, Annangudi SP, Salomon RG, Kuchtey RW, Peachey NS, Crabb JW. Cochlin deposits in the trabecular mesh-work of the glaucomatous DBA/2J mouse. Exp Eye Res. 2005;80: 741-744.
14. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006;47:226-234.
15. Gottanka J, Chan D, Eichhorn M, Lütjen-Drecoll E, Ethier CR. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153-158.
16. Hu Y, Gabelt BT, Kaufman PL. Monkey organ-cultured anterior segments: technique and response to H-7. Exp Eye Res. 2006;82: 1100-1108.
17. Bachmann B, Birke M, Kook D, Eichhorn M, Lütjen-Drecoll E. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci. 2006;47: 2011-2020.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
19. Tian B, Hu Y, Gabelt BT, Kaufman PL. Factors affecting outflow facility calculations. Exp Eye Res. 2006;83:1515-1520.
20. Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003;14:86-90.
21. Kamarinos M, McGill J, Lynch M, Dahl H. Identification of a novel COCH mutation, I109N, highlights the similar clinical features observed in DFNA9 families. Hum Mutat. 2001;17:351.
22. Robertson NG, Cremers CW, Huygen PL, et al. Cochlin immuno-staining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction. Hum Mol Genet. 2006;15:1071-1085.
23. Robertson NG, Lu L, Heller S, et al. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet. 1998;20:299-303.
24. Ikezono T, Shindo S, Ishizaki M, et al. Expression of cochlin in the vestibular organ of rats. ORL J Otorhinolaryngol Relat Spec. 2005; 67:252-258.
25. Cremers CW, Kemperman MH, Bom SJ, Huygen PL, Verhagen WI, Kremer JM. From gene to disease; a progressive cochlear-vestibular dysfunction with onset in middle-age (DFNA9) (in Dutch). Ned Tijdschr Geneeskd. 2005;149:2619-2621.
26. Picciani R, Desai K, Guduric-Fuchs J, Cogliati T, Morton CC, Bhattacharya SK. Cochlin in the eye: functional implications. Prog Retin Eye Res. 2007;26:453-469.